BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16671371)

  • 41. Sentinel lymph node biopsy as the standard of care for cutaneous melanoma.
    Sondak VK; Zager JS; Messina JL; Thomas JM
    Clin Adv Hematol Oncol; 2007 Jun; 5(6):483-90. PubMed ID: 17679922
    [No Abstract]   [Full Text] [Related]  

  • 42. Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy.
    McHugh JB; Su L; Griffith KA; Schwartz JL; Wong SL; Cimmino V; Chang AE; Johnson TM; Sabel MS
    Ann Surg Oncol; 2006 Sep; 13(9):1216-23. PubMed ID: 16952026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reliability of sentinel lymph node biopsy for staging melanoma.
    Majumder B
    Br J Surg; 2000 Sep; 87(9):1250-1. PubMed ID: 10973420
    [No Abstract]   [Full Text] [Related]  

  • 44. Mitotic rate and sentinel lymph node tumor burden topography: integration into melanoma staging and stratification use in clinical trials.
    Averbook BJ
    J Clin Oncol; 2011 Jun; 29(16):2137-41. PubMed ID: 21519024
    [No Abstract]   [Full Text] [Related]  

  • 45. [Study of variations between surgeons regarding inguinal lymph node clearance in melanoma].
    Danino MA; Trost O; Malka G; Garrido I; Jebrane A; Dalac S
    Ann Dermatol Venereol; 2008 Feb; 135(2):142-4. PubMed ID: 18342100
    [No Abstract]   [Full Text] [Related]  

  • 46. A glimpse of future management of melanoma.
    Cochran AJ
    Arch Dermatol; 2009 Oct; 145(10):1176-7. PubMed ID: 19841407
    [No Abstract]   [Full Text] [Related]  

  • 47. Sentinel lymph node biopsy and completion lymph node dissection for malignant melanoma are not standard of care.
    Coldiron BM; Dinehart S; Rogers HW
    Clin Dermatol; 2009; 27(4):350-4. PubMed ID: 19539161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Malignant melanoma of the penis].
    Ostergård H
    Ugeskr Laeger; 1992 Oct; 154(41):2837-8. PubMed ID: 1413228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk stratification in penile carcinoma: 25-year experience with surgical inguinal lymph node staging.
    Hungerhuber E; Schlenker B; Karl A; Frimberger D; Rothenberger KH; Stief CG; Schneede P
    Urology; 2006 Sep; 68(3):621-5. PubMed ID: 16979733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis.
    Doeden K; Ma Z; Narasimhan B; Swetter SM; Detmar M; Dadras SS
    J Cutan Pathol; 2009 Jul; 36(7):772-80. PubMed ID: 19032379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sentinel lymphadenectomy for cutaneous melanoma: who, what, and why.
    Bower M; Scoggins CR
    J Ky Med Assoc; 2009 Jul; 107(7):253-8. PubMed ID: 19678500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sentinel node mapping for melanoma: results of trials and current applications.
    Thompson JF; Shaw HM
    Surg Oncol Clin N Am; 2007 Jan; 16(1):35-54. PubMed ID: 17336235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Surgical technique and postoperative morbidity following radical inguinal/iliacal lymph node dissection--a prospective study in 67 patients with malignant melanoma metastatic to the groin].
    Mall JW; Reetz C; Koplin G; Schäfer-Hesterberg G; Voit C; Neuss H
    Zentralbl Chir; 2009 Sep; 134(5):437-42. PubMed ID: 19757344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Malignant melanoma of the penis].
    Landthaler M; Alvanopoulos K; Braun-Falco O
    Hautarzt; 1990 Feb; 41(2):72-4. PubMed ID: 2318641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Sentinel lymph node biopsy and incidence of recurrence].
    Hautarzt; 2006 Mar; 57(3):182. PubMed ID: 17429861
    [No Abstract]   [Full Text] [Related]  

  • 57. New advances of sentinel node detection in penile carcinoma with clinical implications and a perspective on possible further research.
    Sherif AM
    Eur Urol; 2010 Nov; 58(5):681-3. PubMed ID: 20828921
    [No Abstract]   [Full Text] [Related]  

  • 58. Should the dynamic sentinel node biopsy (DSNB) be considered the gold standard in the evaluation of lymph node status in patients with penile carcinoma?
    Ficarra V; Galfano A
    Eur Urol; 2007 Jul; 52(1):17-9; discussion 20-1. PubMed ID: 17376585
    [No Abstract]   [Full Text] [Related]  

  • 59. Sentinel lymph node micrometastasis may predict non-sentinel involvement in cutaneous melanoma patients.
    Glumac N; Hocevar M; Zadnik V; Snoj M
    J Surg Oncol; 2008 Jul; 98(1):46-8. PubMed ID: 18452214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma.
    Pearlman NW; McCarter MD; Frank M; Hurtubis C; Merkow RP; Franklin WA; Gonzalez R; Lewis K; Roaten JB; Robinson WA
    Am J Surg; 2006 Dec; 192(6):878-81. PubMed ID: 17161112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.